MedPath

Effect of intravenous morphine sulfate and intranasal dexmedetomidine on Patients' Pai

Not Applicable
Recruiting
Conditions
extremity fracture.
Pathological fracture, not elsewhere classified
Registration Number
IRCT20111114008104N15
Lead Sponsor
Iran University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
60
Inclusion Criteria

Organ trauma leading to acute fractures
Patients over the eighteen years old

Exclusion Criteria

Loss of consciousness
Chronic kidney and coronary artery disease
Pregnancy
Drinking alcohol and drugs

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Severity of pain after prescribing. Timepoint: After 15, 30, 60 and 120 minutes after using the drug. Method of measurement: From 1 to 10 (Based on numerical scale).;Total dosage of the drug. Timepoint: After the end of treatment. Method of measurement: Based on the information in the patient file.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath